Nithiodote Kit
NDC Package 60267-812-00
Package Information
Nithiodote (sodium nitrite and sodium thiosulfate) kits is nITHIODOTE is indicated for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. This formulation utilizes a kit delivery system. Marketed by Hope Pharmaceuticals, this product is identified by NDC 60267-812 and is authorized under FDA application NDA201444.
Identification & Billing
- RxCUI: 1086835 - {1 (10 ML sodium nitrite 30 MG/ML Injection) / 1 (50 ML sodium thiosulfate 250 MG/ML Injection) } Pack
- RxCUI: 1086835 - sodium nitrite 300 MG in 10 ML Injection / sodium thiosulfate 12.5 GM in 50 ML Injection Pack
- RxCUI: 1086835 - sodium nitrite 300 MG per 10 ML / sodium thiosulfate 12.5 GM per 50 ML Injection Kit
- RxCUI: 1086836 - {1 (10 ML sodium nitrite 30 MG/ML Injection) / 1 (50 ML sodium thiosulfate 250 MG/ML Injection) } Pack [Nithiodote]
- RxCUI: 1086836 - Nithiodote Pack
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60267 - Hope Pharmaceuticals
- 60267-812 - Nithiodote
- 60267-812-00 - 1 KIT in 1 CARTON * 10 mL in 1 VIAL, SINGLE-USE (60267-311-10) * 50 mL in 1 VIAL, SINGLE-DOSE (60267-705-50)
- 60267-812 - Nithiodote
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60267-812-00 identifies a specific commercial package of 1 kit in 1 carton * 10 ml in 1 vial, single-use (60267-311-10) * 50 ml in 1 vial, single-dose (60267-705-50) of Nithiodote, a human prescription drug labeled by Hope Pharmaceuticals. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hope Pharmaceuticals on January 14, 2011. The current certification is valid through December 31, 2026.
How is this Hope Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60267081200. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
